USPTO trademark

LABCORP

Opposition periodUSPTOWord markClass 5Class 9Class 10Class 42+1

"LABCORP" is a word mark owned by Laboratory Corporation of America Holdings, filed at the USPTO on May 6, 2026. It is in its opposition period and covers classes 5, 9, 10, 42 and 44.

Official USPTO record
LABCORP trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 6, 2026
Filed
May 6, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99806547
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns LABCORP

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services LABCORP is filed for, grouped by Nice class.

  • Clinical medical assays and reagents for medical diagnostic use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing liquid biopsy samples for medical diagnostic purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing liquid biopsy samples for medical diagnostic purposes; Medical diagnostic reagents and assays to test stool samples; Medical testing kits comprised of medical diagnostic reagents and assays for testing stool samples for medical purposes; Medical diagnostic assays for detecting the presence of antibodies for medical purposes; Diagnostic kits for medical use comprised of medical diagnostic reagents and assays for testing for the presence of antibodies; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Medical diagnostic assays for pharmaceutical and medical use to detect the presence of neutralizing antibodies; Diagnostic preparations in the nature of companion compounds for medical use; companion diagnostic agents for medical use; Specimen collection kits for use in virus testing comprised primarily of medical diagnostic reagents and also including collection tubes, lancets, swabs, and collection envelopes for medical purposes; Specimen collection kits for use in genetic testing comprised primarily of medical diagnostic reagents

  • Downloadable computer software for managing, collecting, tracking, and analyzing data in the fields of laboratory testing, diagnostic testing, and clinical trials; downloadable computer software for managing clinical trial operations, namely, software for tracking clinical trial participants, recording clinical trial data, monitoring clinical trial progress, and managing clinical trial protocols; downloadable computer software for collecting, processing, and analyzing medical and diagnostic information; downloadable computer software for monitoring clinical trial subjects and tracking subject compliance with clinical trial protocols; downloadable computer software for managing laboratory information, laboratory test results, and diagnostic testing data; downloadable computer software for tracking, storing, and analyzing medical information related to clinical trial participants and laboratory test results; downloadable computer software for providing information in the fields of laboratory testing, clinical testing, medical testing, diagnostic testing, and genetic testing

  • Diagnostic test kits for medical use comprised of devices for collecting bodily fluid samples, namely, collection tubes, lancets, probes, and collection pouches for medical diagnostic testing purposes; Diagnostic test kits comprised of medical implements in the nature of stool collection tubes, swabs for medical use, collection envelopes, and containers for collecting patient stool samples for medical analysis; Genetic testing kits for medical purposes comprised of devices for collecting bodily fluid samples, namely, collection tubes, lancets, probes, collection envelopes, and swabs; DNA collection kits for medical purposes comprised of DNA collection swabs, protective medical specimen tubes, and integrated desiccants; Biosample specimen collection tubes, namely, collection tubes for blood or plasma samples; Medical diagnostic test kits for testing for drugs of abuse, comprised primarily of medical diagnostic test apparatus and also including chemical reagents; Diagnostic immunoassay test apparatus for medical use; Medical diagnostic apparatus for testing for drugs of abuse

  • Scientific laboratory services; laboratory analysis and testing services for scientific research and product development; laboratory testing services in the fields of biotechnology, pharmaceuticals, biologics, vaccines, and medical products; laboratory testing and analysis services in connection with drug discovery, drug development, and pharmaceutical research; central laboratory services for clinical research studies and clinical trials; laboratory testing and analysis of biological, chemical, and molecular samples for research purposes; biomarker discovery, development, and testing services for scientific and research purposes; bioanalytical laboratory testing services; genomic, molecular, and proteomic analysis for scientific research purposes; genetic analysis and sequencing services for scientific research purposes; assay development, validation, and optimization services for research and drug development; pharmacogenomic and pharmacogenetic laboratory testing services for research purposes; laboratory services for analyzing blood, tissue, cellular, and other biological specimens for research purposes; microbiology, virology, immunology, hematology, and molecular biology laboratory research services; laboratory testing services for evaluating biomarkers, antibodies, hormones, pathogens, and molecular targets for scientific research; laboratory testing and analysis services for pharmaceutical quality control, formulation analysis, and chemistry, manufacturing, and controls (CMC) studies; laboratory sample processing, preparation, and analysis for research and clinical trial purposes; laboratory services for the collection, processing, storage, and management of biological specimens for research purposes; biorepository and biobank services, namely, storage of biological samples for scientific research; scientific laboratory services for biomarker identification, gene expression profiling, genotyping, and sequencing; and scientific consulting relating to laboratory testing and analysis in the fields of pharmaceuticals, biotechnology, and clinical research; Software as a service (SaaS) services featuring software for managing, collecting, tracking, and analyzing data in the fields of laboratory testing, diagnostic testing, and clinical trials; providing temporary use of non-downloadable software for managing clinical trial operations, namely, software for tracking clinical trial participants, recording clinical trial data, monitoring clinical trial progress, and managing clinical trial protocols; providing temporary use of non-downloadable software for collecting, processing, and analyzing medical and diagnostic information; providing temporary use of non-downloadable software for monitoring clinical trial subjects and tracking subject compliance with clinical trial protocols; providing temporary use of non-downloadable software for managing laboratory information, laboratory test results, and diagnostic testing data; providing temporary use of non-downloadable software for tracking, storing, and analyzing medical information related to clinical trial participants and laboratory test results; providing temporary use of non-downloadable software for providing information in the fields of laboratory testing, clinical testing, medical testing, diagnostic testing, and genetic testing

  • Medical laboratory services; clinical diagnostic laboratory testing services; medical diagnostic testing services for the diagnosis, monitoring, and treatment of disease and medical conditions; diagnostic testing of biological samples for medical purposes; laboratory testing services for medical diagnostic purposes; genetic testing for medical purposes; molecular diagnostic testing services for medical purposes; biomarker testing for medical diagnostic and prognostic purposes; diagnostic testing services involving the analysis of blood, urine, tissue, saliva, and other biological specimens for medical purposes; pathology and clinical pathology laboratory services; microbiology, virology, immunology, hematology, and clinical chemistry testing services for medical diagnostic purposes; pharmacogenetic and pharmacogenomic testing for medical purposes; infectious disease testing services for medical purposes; cancer diagnostic testing services; medical testing services for detecting genetic conditions, inherited disorders, and disease susceptibility; providing medical information relating to laboratory testing, diagnostic testing, clinical testing, and genetic testing

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Assigned to examiner
  6. New application office supplied data entered
  7. Application filing receipt mailed
  8. New application entered
FAQ

About LABCORP

Who owns the trademark "LABCORP"?

The USPTO trademark "LABCORP" (application 99806547) is owned by Laboratory Corporation of America Holdings.

What is the status of "LABCORP"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LABCORP and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019e28e4-c32a-762e-882e-2d70e9b2bb65
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019e28e4-c32a-762e-882e-2d70e9b2bb65",
  "object": "trademark",
  "mark_text": "LABCORP",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99806547",
  "filing_date": "2026-05-06",
  "nice_classes": [
    5,
    9,
    10,
    42,
    44
  ],
  "owners": [
    {
      "name": "Laboratory Corporation of America Holdings",
      "entity_id": "ent_019f2860-e50e-7328-8f51-503130b24f7c"
    }
  ]
}